Research Topics
| Rafael F DuarteSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use dataR F Duarte
Department of Haematology, Catalan Institute of Oncology, Barcelona, Spain
Bone Marrow Transplant 46:52-8. 2011..5 ± 2.4; 8-33). In our experience, plerixafor offers an effective alternative to collect sufficient CD34+ cells for autologous SCT from patients who fail conventional mobilization methods, with good tolerance and a high success rate...- Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationRafael F Duarte
Department of Hematology, ICO Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain
J Clin Oncol 28:4492-9. 2010.... - Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005R F Duarte
The Anthony Nolan Trust, Royal Free Hospital, London, UK
Bone Marrow Transplant 37:901-8. 2006.... - Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphomaR F Duarte
Department of Haematology, Institut Catala d Oncologia, Hospital Duran i Reynals, L Hospitalet de Llobregat, Barcelona, Spain
Bone Marrow Transplant 41:597-604. 2008..This review summarizes the experience published to date in this setting and highlights main areas that would merit further investigation... - Practical aspects of allogeneic hematopoietic cell transplantation for patients with poor-risk chronic lymphocytic leukemiaJulio Delgado
Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
ScientificWorldJournal 11:161-72. 2011..Finally, we speculate on how we could improve the results obtained with the procedure and new advances currently in clinical trials... - Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liverRafael F Duarte
Department of Haematology, Royal Free and University College Medical School, London, United Kingdom
Biol Blood Marrow Transplant 11:805-13. 2005..Prospective validation of our findings is warranted... - Identification of non-naïve CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipientsP R Fallen
1Anthony Nolan Research Institute, London, UK
Bone Marrow Transplant 32:609-16. 2003..Furthermore, these results raise important questions regarding the role of the thymus in regulating T cell homeostasis in older HCT recipients and normal individuals... - Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survivalZ Y Lim
Department of Haematological Medicine, Kings College London and Kings College Hospital, London, UK
Bone Marrow Transplant 40:747-52. 2007..22 95% CI 1.82-9.78, P<0.01). Clonal gammopathies are a frequent but benign occurrence following alemtuzumab-based RIC HSCT, and their appearance may define a group of patients with a favourable overall outcome... - Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazoleV H Bigley
Royal Free Hospital, Pond Street, London, UK
Bone Marrow Transplant 34:815-7. 2004..The infection developed despite treatment with 3 mg/kg AmBisome for a concurrent chest infection. She was treated successfully with voriconazole... - Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphomaC Gisselbrecht
Institut d Hematologie, Hopital Saint Louis, Paris, France
Bone Marrow Transplant 40:1007-17. 2007....